Palantir Technologies Inc. (NYSE:PLTR) Shares Sold by Mutual Advisors LLC

Mutual Advisors LLC reduced its holdings in Palantir Technologies Inc. (NYSE:PLTR) by 11.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,743 shares of the company’s stock after selling 4,117 shares during the quarter. Mutual Advisors LLC’s holdings in Palantir Technologies were worth $562,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. AlphaCrest Capital Management LLC acquired a new position in shares of Palantir Technologies during the 1st quarter valued at $206,000. D.A. Davidson & CO. increased its position in shares of Palantir Technologies by 18.6% during the 1st quarter. D.A. Davidson & CO. now owns 14,579 shares of the company’s stock valued at $200,000 after purchasing an additional 2,286 shares during the period. MetLife Investment Management LLC acquired a new position in shares of Palantir Technologies during the 1st quarter valued at $1,475,000. Cibc World Market Inc. increased its position in shares of Palantir Technologies by 38.3% during the 1st quarter. Cibc World Market Inc. now owns 226,834 shares of the company’s stock valued at $3,114,000 after purchasing an additional 62,814 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of Palantir Technologies by 71.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,153,018 shares of the company’s stock valued at $15,832,000 after purchasing an additional 482,171 shares during the period. 45.65% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Palantir Technologies

In related news, Director Peter Thiel sold 7,044,756 shares of Palantir Technologies stock in a transaction on Tuesday, March 12th. The stock was sold at an average price of $24.79, for a total transaction of $174,639,501.24. Following the completion of the sale, the director now owns 70,806,432 shares of the company’s stock, valued at $1,755,291,449.28. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Peter Thiel sold 7,044,756 shares of Palantir Technologies stock in a transaction on Tuesday, March 12th. The stock was sold at an average price of $24.79, for a total transaction of $174,639,501.24. Following the completion of the sale, the director now owns 70,806,432 shares of the company’s stock, valued at $1,755,291,449.28. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Lauren Elaina Friedman Stat sold 6,000 shares of the business’s stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $23.68, for a total value of $142,080.00. Following the completion of the sale, the director now directly owns 175,830 shares of the company’s stock, valued at approximately $4,163,654.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 7,455,273 shares of company stock valued at $184,293,942. Insiders own 13.96% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on PLTR shares. Citigroup upgraded Palantir Technologies from a “sell” rating to a “neutral” rating and lifted their price target for the company from $10.00 to $20.00 in a research report on Tuesday, February 6th. Jefferies Financial Group upgraded Palantir Technologies from an “underperform” rating to a “hold” rating and lifted their target price for the stock from $13.00 to $22.00 in a report on Tuesday, February 6th. Royal Bank of Canada restated an “underperform” rating and issued a $5.00 target price on shares of Palantir Technologies in a report on Tuesday, February 6th. Bank of America lifted their target price on Palantir Technologies from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Wednesday, March 6th. Finally, Raymond James lifted their target price on Palantir Technologies from $22.00 to $25.00 and gave the stock an “outperform” rating in a report on Tuesday, February 6th. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $18.21.

Palantir Technologies Stock Down 1.6 %

Shares of Palantir Technologies stock opened at $24.50 on Thursday. The stock has a market cap of $54.21 billion, a PE ratio of 272.22, a price-to-earnings-growth ratio of 6.01 and a beta of 2.82. The business has a fifty day simple moving average of $22.40 and a 200-day simple moving average of $19.03. Palantir Technologies Inc. has a 12 month low of $7.28 and a 12 month high of $27.50.

Palantir Technologies (NYSE:PLTR) last issued its earnings results on Monday, February 5th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). The business had revenue of $608.35 million during the quarter, compared to analyst estimates of $603.48 million. Palantir Technologies had a return on equity of 6.17% and a net margin of 9.43%. Analysts expect that Palantir Technologies Inc. will post 0.16 EPS for the current fiscal year.

About Palantir Technologies

Palantir Technologies Inc builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally. The company provides Palantir Gotham, a software platform which enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants, as well as facilitates the handoff between analysts and operational users, helping operators plan and execute real-world responses to threats that have been identified within the platform.